Shashank S. Sinha, MD, MSc, FACC, FAHA, FHFSA is an Advanced Heart Failure, Mechanical Circulatory Support, and Transplant Cardiologist at Inova Fairfax Medical Campus, where he has served as Medical Director of the Cardiac Intensive Care Unit, Cardiology, and Director of the Cardiovascular Critical Care Research Program since October 2018. He now also serves as System Director of the Inova Health System Cardiogenic Shock Program as of March 2025. He is an Assistant Professor of Medical Education at the University of Virginia School of Medicine and is board certified in Internal Medicine, Cardiovascular Diseases, and Advanced Heart Failure and Transplant Cardiology.

Dr. Sinha received his undergraduate degree, cum laude in Applied Mathematics, from Harvard University and his medical degree, with honors, from the University of Chicago Pritzker School of Medicine. He was selected to the Alpha Omega Alpha and Gold Humanism Honor Societies and received the Pritzker Leadership Award. He completed his internship and residency in internal medicine at the University of Pennsylvania, earning the Maurice F. Attie Senior Resident Teaching Award. During his residency training, he completed the inaugural two-year certificate program in Healthcare Leadership in Quality at the University of Pennsylvania. He subsequently served as a medical intensive care unit hospitalist at Penn Presbyterian Medical Center. He matriculated to the University of Michigan, where he completed his clinical fellowship training in cardiovascular disease and advanced heart failure and transplant cardiology. Dr. Sinha also completed a two-year research fellowship and Master’s program in Health and Health Care Research at the University of Michigan Institute for Healthcare Policy and Innovation during his NIH T32 Postdoctoral Research Training Program.

Dr. Sinha has a strong clinical and scientific interest in improving the quality of care for patients experiencing cardiac critical illness, including cardiogenic shock, cardiac arrest, and acute heart failure. He has authored nearly 200 publications (h index 42) in top-tier journals including Circulation, Circulation: Heart Failure, JACC, JACC: Heart Failure,  and Journal of Cardiac Failure. He serves as the site Principal Investigator and Executive Steering Committee member for the Cardiogenic Shock Working Group and previously served on the Steering Committee for the Critical Care Cardiology Trials Network. He currently serves as the Chair Elect of the ACC Heart Failure and Transplant Section Leadership Council and Topic Co-Coordinator for the ACC.27 Scientific Sessions. Most recently, he served as the Chair of the 2024 American College of Cardiology Round Table on the “Evaluation and Management of Cardiogenic Shock,” which culminated in the first ACC Concise Clinical Guidance published on the topic in JACC in 2025.

Dr. Sinha now serves as the Deputy Editor for the Journal of Cardiac Failure since October 2024 where he previously served as Associate Editor for JCF since January 2021. His prior editorial experience includes former Section Editor for the JACC Fellows-in-Training/Early Career Page and as a former CME/Social Media Editor for JACC: Heart Failure. Dr. Sinha has also been recognized with the 2017 American Medical Association’s Excellence in Medicine Leadership Award and was inducted into the American College of Cardiology’s Leadership Academy. He subsequently completed both the ACC Emerging Faculty and Emerging Faculty: Advanced Concepts courses. Dr. Sinha completed the highly competitive Class of 2024 Presidential Leadership Scholars Program, a leadership development program organized by the centers and staff of former U.S. Presidents George W. Bush, Bill Clinton, George H.W. Bush, and Lyndon B. Johnson.